Brief: Cyclacel Pharmaceuticals - Received Nasdaq Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard Transfer Of Listing On Jan 4

Bio Green Med Solution

06/01/2023 21:21

Jan 6 (Reuters) - Cyclacel Pharmaceuticals Inc  CYCC.O :
    * CYCLACEL PHARMACEUTICALS - RECEIVED NASDAQ NOTICE OF
DELISTING
OR FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD;
TRANSFER OF LISTING ON JAN 4

Further company coverage:  CYCC.O 
 ((Reuters.Briefs@thomsonreuters.com;;))